Feature | July 16, 2013

Latest Report Shows Rebound in Radiation Therapy Market

July 16, 2013 — The U.S. radiation therapy market appears to be rebounding after a major decline in 2009, with radiation oncology centers budgeting more money for capital equipment purchases this year compared to four years ago, according to a new study published by IMV Medical Information Division.

The average capital equipment budget per site for 2013 is 30 percent higher than the average 2009 budget, according to IMV's 2012/13 Radiation Therapy Market Summary Report. The report also found that patient volume has been relatively stable over the years. “The estimated number of courses of treatment — a measure that corresponds to patient volume — was at a level of 965,620 in 2012,” observed Lorna Young, senior director, market research at IMV. “This level of patient volume has been relatively stable over the past decade, increasing at an average annual rate of less than 1 percent.”

While the numbers of patients have been relatively consistent, improvements in radiation therapy technologies are continuing to drive capital purchases. IMV reports that managers of radiation oncology centers are budgeting for new equipment purchases that incorporate treatment technologies such as image-guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT) and rotational arc therapy, which help to deliver safe and effective radiation treatments to patients.

The research indicates that more than one-third (38 percent) of the radiation therapy sites in the survey are planning to purchase external-beam radiation therapy (EBRT) units as replacement or additional units over the next three years, including linear accelerators, CyberKnife, Gamma Knife, TomoTherapy and proton therapy units.

Nearly half (45 percent) of radiation therapy sites are planning to acquire or upgrade their oncology information systems (OIS) over the next three years, with 80 percent of the planned implementations and upgrades of systems incorporating electronic medical record (EMR) data.

“Additional drivers for purchasing activity by radiation therapy facilities are to increase the IT [information technology] capabilities of information systems and to incorporate imaging into all phases of the radiation therapy workflow, with the goal of improving the accuracy of radiation therapy treatments,” Young said. “As a result, we are seeing that the proportion of radiation therapy sites budgeting capital budgets of $2.0 million or more is expected to grow, from 13 percent in 2012 to 24 percent in 2014.”

The report describes trends in the adoption of therapeutic techniques, equipment and radioactive agents. Equipment types covered include external-beam therapy units, simulators [including computed tomography (CT), positron emission tomography/computed tomography (PET/CT), magnetic resonance imaging (MR) and X-ray simulators], treatment planning systems, IGRT, record and verify/OIS, and brachytherapy equipment. Other technologies covered include intensity-modulated radiation therapy (IMRT), inverse planning, rotational arc therapy, stereotactic radiosurgery (SRS) and prostate seed therapy. Equipment and software vendors covered in the study include Accuray, Brainlab, Elekta, GE Healthcare, Philips Healthcare, Siemens Healthcare, Toshiba America Medical Systems and Varian Medical Systems.

For more information: www.imvinfo.com

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init